Free Trial
→ Buffett’s $325 Billion Cash Problem — Solved by Gold? (From Golden Portfolio) (Ad) Buy RXO Stock  Free RXO Stock Alerts

RXO (RXO) Financials

RXO logo
$15.74 +0.25 (+1.58%)
Closing price 05/29/2025 03:59 PM Eastern
Extended Trading
$15.77 +0.02 (+0.15%)
As of 05/29/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for RXO

Annual Income Statements for RXO

This table shows RXO's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Income / (Loss) Attributable to Common Shareholders		 -290 4.00 92 150 43
Consolidated Net Income / (Loss)		 -290 4.00 92 150 43
Net Income / (Loss) Continuing Operations		 -290 4.00 92 150 43
Total Pre-Tax Income 		-304 4.00 119 191 57
Total Operating Income		 -56 39 123 192 60
Total Gross Profit		 985 960 1,172 1,008 789
Total Revenue		 4,550 3,927 4,796 4,689 3,357
Operating Revenue		 4,550 3,927 4,796 4,689 3,357
Total Cost of Revenue		 3,565 2,967 3,624 3,681 2,568
Operating Cost of Revenue		 3,565 2,967 3,624 3,681 2,568
Total Operating Expenses		 1,041 921 1,049 816 729
Selling, General & Admin Expense		 666 591 640 539 455
Depreciation Expense		 87 67 86 81 76
Other Operating Expenses / (Income)		 202 235 226 192 174
Restructuring Charge		 86 28 97 4.00 24
Total Other Income / (Expense), net		 -248 -35 -4.00 -1.00 -3.00
Interest & Investment Income		 -30 -32 -4.00 0.00 0.00
Other Income / (Expense), net		 -218 -3.00 0.00 -1.00 -3.00
Income Tax Expense		 -14 0.00 27 41 14
Basic Earnings per Share		 ($2.17) $0.03 $0.80 $1.30 $0.37
Weighted Average Basic Shares Outstanding		 133.41M 116.87M 115.34M 115.16M 115.16M
Diluted Earnings per Share		 ($2.17) $0.03 $0.79 $1.30 $0.37
Weighted Average Diluted Shares Outstanding		 133.41M 119.46M 115.79M 115.16M 115.16M
Weighted Average Basic & Diluted Shares Outstanding		 163.33M 117.09M 116.60M - -

Quarterly Income Statements for RXO

This table shows RXO's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -31 -27 -243 -7.00 -13 2.00 -1.00 3.00 0.00 -5.00 15
Consolidated Net Income / (Loss)		 -31 -25 -243 -7.00 -15 2.00 -1.00 3.00 0.00 -4.00 13
Net Income / (Loss) Continuing Operations		 -31 -27 -243 -7.00 -13 2.00 -1.00 3.00 0.00 -5.00 15
Total Pre-Tax Income 		-39 -33 -242 -8.00 -21 4.00 -3.00 6.00 -3.00 -6.00 15
Total Operating Income		 -30 -24 -20 0.00 -12 14 6.00 14 5.00 -1.00 15
Total Gross Profit		 280 310 231 230 214 235 234 240 251 278 281
Total Revenue		 1,433 1,667 1,040 930 913 978 976 963 1,010 1,120 1,138
Operating Revenue		 1,433 1,667 1,040 930 913 978 976 963 1,010 1,120 1,138
Total Cost of Revenue		 1,153 1,357 809 700 699 743 742 723 759 842 857
Operating Cost of Revenue		 1,153 1,357 809 700 699 743 742 723 759 842 857
Total Operating Expenses		 310 334 251 230 226 221 228 226 246 279 266
Selling, General & Admin Expense		 210 218 149 154 145 146 148 144 153 155 158
Depreciation Expense		 32 33 21 17 16 15 16 18 18 21 23
Other Operating Expenses / (Income)		 48 50 49 50 53 56 59 59 61 59 56
Restructuring Charge		 20 33 32 9.00 12 4.00 5.00 5.00 14 44 29
Total Other Income / (Expense), net		 -9.00 -11 -222 -8.00 -7.00 -10 -9.00 -8.00 -8.00 -6.00 2.00
Interest & Investment Income		 -9.00 -8.00 -6.00 -8.00 -8.00 -8.00 -8.00 -8.00 -8.00 -5.00 1.00
Other Income / (Expense), net		 0.00 -3.00 -216 0.00 1.00 -2.00 -1.00 0.00 0.00 - 1.00
Income Tax Expense		 -8.00 -8.00 1.00 -1.00 -6.00 2.00 -2.00 3.00 -3.00 -2.00 2.00
Basic Earnings per Share		 ($0.18) ($0.17) ($1.81) ($0.06) ($0.13) $0.01 ($0.01) $0.03 $0.00 ($0.03) $0.11
Weighted Average Basic Shares Outstanding		 168.02M 133.41M 134.10M 117.58M 117.22M 116.87M 116.97M 116.89M 116.60M 115.34M 115.16M
Diluted Earnings per Share		 ($0.18) ($0.17) ($1.81) ($0.06) ($0.13) $0.01 ($0.01) $0.03 $0.00 ($0.04) $0.11
Weighted Average Diluted Shares Outstanding		 168.02M 133.41M 134.10M 117.58M 117.22M 119.46M 116.97M 119.46M 119.37M 115.79M 115.16M
Weighted Average Basic & Diluted Shares Outstanding		 163.92M 163.33M 160.79M 117.63M 117.55M 117.09M 117.00M 116.98M 116.92M 116.60M 116.30M

Annual Cash Flow Statements for RXO

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Change in Cash & Equivalents		 30 -93 69 -41 19
Net Cash From Operating Activities		 -12 89 310 155 25
Net Cash From Continuing Operating Activities		 -12 89 310 155 25
Net Income / (Loss) Continuing Operations		 -290 4.00 92 150 43
Consolidated Net Income / (Loss)		 -290 4.00 92 150 43
Depreciation Expense		 87 67 86 81 76
Non-Cash Adjustments To Reconcile Net Income		 259 28 38 11 22
Changes in Operating Assets and Liabilities, net		 -68 -10 94 -87 -116
Net Cash From Investing Activities		 -1,064 -66 -56 -38 -39
Net Cash From Continuing Investing Activities		 -1,064 -66 -56 -38 -39
Purchase of Property, Plant & Equipment		 -45 -64 -57 -39 -47
Acquisitions		 -1,019 0.00 0.00 - -
Sale of Property, Plant & Equipment		 0.00 0.00 1.00 1.00 8.00
Other Investing Activities, net		 0.00 -2.00 0.00 0.00 -
Net Cash From Financing Activities		 1,108 -117 -183 -158 32
Net Cash From Continuing Financing Activities		 1,108 -117 -183 -158 32
Repayment of Debt		 -221 -177 -10 1.00 0.00
Repurchase of Common Equity		 -30 -2.00 0.00 0.00 -
Issuance of Debt		 238 76 451 0.00 0.00
Issuance of Common Equity		 1,125 0.00 0.00 - -
Other Financing Activities, net		 -4.00 -14 -624 -159 32
Effect of Exchange Rate Changes		 -2.00 1.00 -2.00 0.00 1.00
Cash Interest Paid		 27 32 0.00 0.00 -
Cash Income Taxes Paid		 4.00 27 3.00 5.00 2.00

Quarterly Cash Flow Statements for RXO

This table details how cash moves in and out of RXO's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -19 -20 48 - 2.00 -99 -20 3.00 23 -89 -25
Net Cash From Operating Activities		 -2.00 -7.00 -7.00 -5.00 7.00 19 4.00 24 42 76 57
Net Cash From Continuing Operating Activities		 -2.00 -7.00 -7.00 -5.00 7.00 19 4.00 24 42 76 57
Net Income / (Loss) Continuing Operations		 -31 -25 -243 -7.00 -15 2.00 -1.00 3.00 0.00 -4.00 13
Consolidated Net Income / (Loss)		 -31 -25 -243 -7.00 -15 2.00 -1.00 3.00 0.00 -4.00 13
Depreciation Expense		 32 33 21 17 16 15 16 18 18 21 23
Non-Cash Adjustments To Reconcile Net Income		 13 23 223 6.00 7.00 8.00 8.00 6.00 6.00 23 4.00
Changes in Operating Assets and Liabilities, net		 -16 -38 -8.00 -21 -1.00 -6.00 -19 -3.00 18 36 17
Net Cash From Investing Activities		 -25 -12 -1,030 -11 -11 -19 -19 -16 -12 -18 -14
Net Cash From Continuing Investing Activities		 -25 -12 -1,030 -11 -11 -19 -19 -16 -12 -18 -14
Purchase of Property, Plant & Equipment		 -15 -12 -11 -11 -11 -18 -18 -16 -12 -18 -15
Acquisitions		 -10 - - - - - - - - - -
Net Cash From Financing Activities		 7.00 1.00 1,085 16 6.00 -100 -4.00 -5.00 -8.00 -145 -68
Net Cash From Continuing Financing Activities		 7.00 1.00 1,085 16 6.00 -100 -4.00 -5.00 -8.00 -145 -68
Repayment of Debt		 -276 -34 -93 -63 -31 -174 -1.00 -1.00 -1.00 -11 1.00
Issuance of Debt		 300 35 84 80 39 76 - - 0.00 - -
Other Financing Activities, net		 -17 - -1.00 -1.00 -2.00 -2.00 -3.00 -2.00 -7.00 -585 -69
Effect of Exchange Rate Changes		 1.00 -2.00 - - 0.00 1.00 -1.00 - 1.00 -2.00 -
Cash Interest Paid		 2.00 14 -2.00 14 1.00 14 1.00 17 0.00 - -
Cash Income Taxes Paid		 1.00 1.00 1.00 1.00 1.00 2.00 4.00 15 6.00 - -

Annual Balance Sheets for RXO

This table presents RXO's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Total Assets		 3,414 1,825 2,031 2,068
Total Current Assets		 1,339 796 1,029 1,083
Cash & Equivalents		 35 5.00 98 29
Accounts Receivable		 1,227 743 900 1,010
Other Current Assets		 77 48 31 44
Plant, Property, & Equipment, net		 135 124 119 0.00
Total Noncurrent Assets		 1,940 905 883 985
Goodwill		 1,123 630 630 630
Intangible Assets		 499 68 79 100
Other Noncurrent Operating Assets		 318 207 174 255
Total Liabilities & Shareholders' Equity		 3,414 1,825 2,031 2,068
Total Liabilities		 1,802 1,231 1,444 998
Total Current Liabilities		 1,065 682 823 816
Short-Term Debt		 17 3.00 4.00 0.00
Accounts Payable		 568 414 501 520
Accrued Expenses		 373 199 256 248
Other Current Liabilities		 107 66 62 48
Total Noncurrent Liabilities		 737 549 621 182
Long-Term Debt		 351 356 451 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 88 7.00 16 52
Other Noncurrent Operating Liabilities		 298 186 154 130
Commitments & Contingencies		 0.00 0.00 0.00 -
Total Equity & Noncontrolling Interests		 1,612 594 587 1,070
Total Preferred & Common Equity		 1,612 594 587 1,070
Preferred Stock		 0.00 0.00 0.00 -
Total Common Equity		 1,612 594 587 1,070
Common Stock		 1,906 591 589 -
Retained Earnings		 -284 6.00 2.00 -
Accumulated Other Comprehensive Income / (Loss)		 -10 -3.00 -4.00 -2.00

Quarterly Balance Sheets for RXO

This table presents RXO's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 3,304 3,392 1,813 1,799 1,946 1,912 2,018 2,237
Total Current Assets		 1,255 1,255 776 770 936 916 1,029 1,225
Cash & Equivalents		 16 55 7.00 7.00 104 124 121 187
Accounts Receivable		 1,150 1,138 725 716 787 743 862 1,012
Other Current Assets		 89 62 44 47 45 49 46 26
Plant, Property, & Equipment, net		 143 175 118 121 122 116 0.00 0.00
Total Noncurrent Assets		 1,906 1,962 919 908 888 880 989 1,012
Goodwill		 1,124 1,027 630 630 630 630 630 630
Intangible Assets		 484 565 62 65 72 73 76 85
Other Noncurrent Operating Assets		 298 370 227 213 186 177 283 297
Total Liabilities & Shareholders' Equity		 3,304 3,392 1,813 1,799 1,946 1,912 2,018 2,237
Total Liabilities		 1,717 1,740 1,234 1,217 1,356 1,323 1,433 1,093
Total Current Liabilities		 964 947 662 674 728 699 820 888
Short-Term Debt		 17 15 16 16 3.00 4.00 4.00 5.00
Accounts Payable		 498 572 382 372 448 432 496 547
Accrued Expenses		 358 262 197 220 221 210 265 284
Other Current Liabilities		 91 98 67 66 56 53 55 52
Total Noncurrent Liabilities		 753 793 572 543 628 624 613 205
Long-Term Debt		 387 352 370 351 451 451 451 6.00
Noncurrent Deferred & Payable Income Tax Liabilities		 77 115 0.00 1.00 15 17 16 44
Other Noncurrent Operating Liabilities		 289 326 202 191 162 156 146 155
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 - -
Total Equity & Noncontrolling Interests		 1,587 1,652 579 582 590 589 -4.00 1,144
Total Preferred & Common Equity		 1,587 1,652 579 582 590 589 585 1,144
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 - -
Total Common Equity		 1,587 1,652 579 582 590 589 -4.00 1,144
Common Stock		 1,910 1,916 600 594 590 588 - -
Retained Earnings		 -315 -259 -16 -9.00 4.00 5.00 - -
Accumulated Other Comprehensive Income / (Loss)		 -8.00 -5.00 -5.00 -3.00 -4.00 -4.00 -4.00 -4.00

Annual Metrics And Ratios for RXO

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Growth Metrics		 - - - - -
Revenue Growth		 15.86% -18.12% 2.28% 39.68% 0.00%
EBITDA Growth		 -281.55% -50.72% -23.16% 104.51% 0.00%
EBIT Growth		 -861.11% -70.73% -35.60% 235.09% 0.00%
NOPAT Growth		 -200.51% -58.99% -36.94% 233.13% 0.00%
Net Income Growth		 -7,350.00% -95.65% -38.67% 248.84% 0.00%
EPS Growth		 -7,333.33% -96.20% -39.23% 251.35% 0.00%
Operating Cash Flow Growth		 -113.48% -71.29% 100.00% 520.00% 0.00%
Free Cash Flow Firm Growth		 -3,060.57% -81.78% 121.58% 0.00% 0.00%
Invested Capital Growth		 105.17% 0.42% -9.32% 0.00% 0.00%
Revenue Q/Q Growth		 17.85% -3.49% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -12.65% 6.19% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 -16.60% 50.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 -211.11% 132.14% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 -10.27% 300.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 -9.05% 250.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -185.71% -39.04% 14.81% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.04% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -0.97% 0.85% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 21.65% 24.45% 24.44% 21.50% 23.50%
EBITDA Margin		 -4.11% 2.62% 4.36% 5.80% 3.96%
Operating Margin		 -1.23% 0.99% 2.56% 4.09% 1.79%
EBIT Margin		 -6.02% 0.92% 2.56% 4.07% 1.70%
Profit (Net Income) Margin		 -6.37% 0.10% 1.92% 3.20% 1.28%
Tax Burden Percent		 95.39% 100.00% 77.31% 78.53% 75.44%
Interest Burden Percent		 110.95% 11.11% 96.75% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 22.69% 21.47% 24.56%
Return on Invested Capital (ROIC)		 -2.71% 4.12% 9.58% 28.97% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -75.72% -5.72% 7.70% 34.39% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -23.58% -3.45% 1.52% -0.93% 0.00%
Return on Equity (ROE)		 -26.29% 0.68% 11.10% 28.04% 0.00%
Cash Return on Invested Capital (CROIC)		 -71.64% 3.70% 19.35% -171.03% 0.00%
Operating Return on Assets (OROA)		 -10.46% 1.87% 6.00% 9.24% 0.00%
Return on Assets (ROA)		 -11.07% 0.21% 4.49% 7.25% 0.00%
Return on Common Equity (ROCE)		 -26.29% 0.68% 11.10% 28.04% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -17.99% 0.67% 15.67% 14.02% 0.00%
Net Operating Profit after Tax (NOPAT)		 -39 39 95 151 45
NOPAT Margin		 -0.86% 0.99% 1.98% 3.22% 1.35%
Net Nonoperating Expense Percent (NNEP)		 73.01% 9.85% 1.89% -5.42% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -1.98% 4.09% 9.13% - -
Cost of Revenue to Revenue		 78.35% 75.55% 75.56% 78.50% 76.50%
SG&A Expenses to Revenue		 14.64% 15.05% 13.34% 11.50% 13.55%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 22.88% 23.45% 21.87% 17.40% 21.72%
Earnings before Interest and Taxes (EBIT)		 -274 36 123 191 57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -187 103 209 272 133
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 2.38 4.58 3.41 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.84 0.69 0.42 0.00 0.00
Price to Earnings (P/E)		 0.00 680.36 21.74 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.15% 4.60% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.14 3.24 2.50 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.92 0.78 0.49 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 29.86 11.28 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 85.43 19.17 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 78.86 24.79 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 34.56 7.60 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 87.87 12.27 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.23 0.60 0.78 0.00 0.00
Long-Term Debt to Equity		 0.22 0.60 0.77 0.00 0.00
Financial Leverage		 0.31 0.60 0.20 -0.03 0.00
Leverage Ratio		 2.37 3.27 2.47 1.93 0.00
Compound Leverage Factor		 2.63 0.36 2.39 1.93 0.00
Debt to Total Capital		 18.59% 37.67% 43.67% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.86% 0.31% 0.38% 0.00% 0.00%
Long-Term Debt to Total Capital		 17.73% 37.36% 43.28% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 81.41% 62.33% 56.33% 100.00% 0.00%
Debt to EBITDA		 -1.97 3.49 2.18 0.00 0.00
Net Debt to EBITDA		 -1.78 3.44 1.71 0.00 0.00
Long-Term Debt to EBITDA		 -1.88 3.46 2.16 0.00 0.00
Debt to NOPAT		 -9.39 9.21 4.78 0.00 0.00
Net Debt to NOPAT		 -8.49 9.08 3.75 0.00 0.00
Long-Term Debt to NOPAT		 -8.95 9.13 4.74 0.00 0.00
Altman Z-Score		 2.32 3.62 3.52 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 1.26 1.17 1.25 1.33 0.00
Quick Ratio		 1.19 1.10 1.21 1.27 0.00
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 -1,036 35 192 -890 0.00
Operating Cash Flow to CapEx		 -26.67% 139.06% 553.57% 407.89% 64.10%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 1.74 2.04 2.34 2.27 0.00
Accounts Receivable Turnover		 4.62 4.78 5.02 4.64 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 35.14 32.32 0.00 0.00 0.00
Accounts Payable Turnover		 7.26 6.49 7.10 7.08 0.00
Days Sales Outstanding (DSO)		 79.02 76.36 72.68 78.62 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 50.27 56.28 51.42 51.56 0.00
Cash Conversion Cycle (CCC)		 28.75 20.07 21.26 27.06 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 1,945 948 944 1,041 0.00
Invested Capital Turnover		 3.15 4.15 4.83 9.01 0.00
Increase / (Decrease) in Invested Capital		 997 4.00 -97 1,041 0.00
Enterprise Value (EV)		 4,166 3,075 2,357 0.00 0.00
Market Capitalization		 3,833 2,721 2,000 0.00 0.00
Book Value per Share		 $10.03 $5.08 $5.05 $9.29 $0.00
Tangible Book Value per Share		 ($0.06) ($0.89) ($1.05) $2.95 $0.00
Total Capital		 1,980 953 1,042 1,070 0.00
Total Debt		 368 359 455 0.00 0.00
Total Long-Term Debt		 351 356 451 0.00 0.00
Net Debt		 333 354 357 -29 0.00
Capital Expenditures (CapEx)		 45 64 56 38 39
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 256 112 112 238 0.00
Debt-free Net Working Capital (DFNWC)		 291 117 210 267 0.00
Net Working Capital (NWC)		 274 114 206 267 0.00
Net Nonoperating Expense (NNE)		 251 35 3.09 0.79 2.26
Net Nonoperating Obligations (NNO)		 333 354 357 -29 0.00
Total Depreciation and Amortization (D&A)		 87 67 86 81 76
Debt-free, Cash-free Net Working Capital to Revenue		 5.63% 2.85% 2.34% 5.08% 0.00%
Debt-free Net Working Capital to Revenue		 6.40% 2.98% 4.38% 5.69% 0.00%
Net Working Capital to Revenue		 6.02% 2.90% 4.30% 5.69% 0.00%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 ($2.17) $0.03 $0.80 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 133.41M 116.87M 115.34M 0.00 0.00
Adjusted Diluted Earnings per Share		 ($2.17) $0.03 $0.79 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 133.41M 119.46M 115.79M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 163.33M 117.09M 116.60M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 21 47 170 154 63
Normalized NOPAT Margin		 0.46% 1.19% 3.55% 3.28% 1.89%
Pre Tax Income Margin		 -6.68% 0.10% 2.48% 4.07% 1.70%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -10.34% 50.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for RXO

This table displays calculated financial ratios and metrics derived from RXO's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 56.96% 70.45% 6.56% -3.43% -9.60% -12.68% -14.24% -21.45% -23.02% 0.00% -5.01%
EBITDA Growth		 -33.33% -77.78% -1,123.81% -46.88% -78.26% 35.00% -46.15% -59.49% -68.06% 0.00% -35.00%
EBIT Growth		 -130.77% -325.00% -4,820.00% -100.00% -320.00% 1,300.00% -68.75% -75.86% -90.20% 0.00% -57.89%
NOPAT Growth		 -150.00% -340.00% -433.33% -100.00% -340.00% 1,100.00% -67.69% -83.82% -91.03% 0.00% -60.61%
Net Income Growth		 -106.67% -1,350.00% -24,200.00% -333.33% 0.00% 150.00% -107.69% -93.18% -100.00% 0.00% -60.61%
EPS Growth		 -38.46% -1,800.00% -18,000.00% -300.00% 0.00% 125.00% -109.09% -92.11% -100.00% 0.00% -62.07%
Operating Cash Flow Growth		 -128.57% -136.84% -275.00% -120.83% -83.33% -75.00% -92.98% -67.57% -59.22% 111.11% 0.00%
Free Cash Flow Firm Growth		 -3,256.69% -33,893.33% -3,323.60% 95.84% 96.57% 0.00% 103.37% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 109.66% 105.17% 108.94% 4.13% 2.50% 0.42% -2.89% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 -14.04% 60.29% 11.83% 1.86% -6.65% 0.20% 1.35% -4.65% -9.82% -1.58% -7.18%
EBITDA Q/Q Growth		 -66.67% 102.79% -1,364.71% 240.00% -80.00% 28.57% -34.38% 39.13% 15.00% -48.72% -50.63%
EBIT Q/Q Growth		 -11.11% 88.56% 0.00% 100.00% -210.00% 140.00% -64.29% 180.00% 600.00% -106.25% -72.41%
NOPAT Q/Q Growth		 -25.00% -20.00% 0.00% 100.00% -220.00% 66.67% -40.00% 100.00% 600.00% -105.38% -69.95%
Net Income Q/Q Growth		 -24.00% 89.71% -3,371.43% 53.33% -850.00% 300.00% -133.33% 0.00% 100.00% -130.77% -70.45%
EPS Q/Q Growth		 -5.88% 90.61% -2,916.67% 53.85% -1,400.00% 200.00% -133.33% 0.00% 100.00% -136.36% -71.05%
Operating Cash Flow Q/Q Growth		 71.43% 0.00% -40.00% -171.43% -63.16% 375.00% -83.33% -42.86% -44.74% 33.33% -22.97%
Free Cash Flow Firm Q/Q Growth		 -3.97% 2.33% -2,631.58% -21.02% -1,146.67% -90.68% 103.53% 0.27% 0.00% 100.00% 0.00%
Invested Capital Q/Q Growth		 1.54% -0.97% 105.01% 1.70% -0.63% 0.85% 2.17% 0.11% -2.65% -2.48% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 19.54% 18.60% 22.21% 24.73% 23.44% 24.03% 23.98% 24.92% 24.85% 24.82% 24.69%
EBITDA Margin		 0.14% 0.36% -20.67% 1.83% 0.55% 2.76% 2.15% 3.32% 2.28% 1.79% 3.43%
Operating Margin		 -2.09% -1.44% -1.92% 0.00% -1.31% 1.43% 0.61% 1.45% 0.50% -0.09% 1.32%
EBIT Margin		 -2.09% -1.62% -22.69% 0.00% -1.20% 1.23% 0.51% 1.45% 0.50% -0.09% 1.41%
Profit (Net Income) Margin		 -2.16% -1.50% -23.37% -0.75% -1.64% 0.20% -0.10% 0.31% 0.00% -0.36% 1.14%
Tax Burden Percent		 79.49% 75.76% 100.41% 87.50% 71.43% 50.00% 33.33% 50.00% 0.00% 66.67% 86.67%
Interest Burden Percent		 130.00% 122.22% 102.54% 0.00% 190.91% 33.33% -60.00% 42.86% -60.00% 600.00% 93.75%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 50.00% 0.00% 50.00% 0.00% 0.00% 13.33%
Return on Invested Capital (ROIC)		 -5.09% -3.17% -3.58% 0.00% -3.79% 2.97% 1.84% 6.69% 3.39% -0.32% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -7.77% -5.56% -72.76% -1.97% -4.82% 1.56% -4.14% 4.27% 2.63% -1.24% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -2.68% -1.73% -21.49% -1.20% -10.69% 0.94% -0.42% 2.40% -607.05% -0.76% 0.00%
Return on Equity (ROE)		 -7.77% -4.90% -25.06% -1.20% -14.48% 3.91% 1.42% 9.08% -603.66% -1.07% 0.00%
Cash Return on Invested Capital (CROIC)		 -74.38% -71.64% -71.39% -3.45% -0.82% 3.70% 0.00% 0.00% 0.00% 20.35% 0.00%
Operating Return on Assets (OROA)		 -4.16% -2.81% -32.83% 0.00% -2.42% 2.50% 1.00% 3.22% 1.10% -0.21% 0.00%
Return on Assets (ROA)		 -4.30% -2.60% -33.80% -1.53% -3.30% 0.42% -0.20% 0.69% 0.00% -0.84% 0.00%
Return on Common Equity (ROCE)		 -7.77% -4.90% -25.06% -1.20% -14.48% 3.91% 1.42% 9.08% -603.66% -1.07% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -19.28% 0.00% -15.92% -3.63% -1.89% 0.00% -0.34% 2.04% 9.06% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -17 -14 0.00 -8.40 7.00 4.20 7.00 3.50 -0.70 13
NOPAT Margin		 -1.47% -1.01% -1.35% 0.00% -0.92% 0.72% 0.43% 0.73% 0.35% -0.06% 1.14%
Net Nonoperating Expense Percent (NNEP)		 2.67% 2.39% 69.18% 1.97% 1.03% 1.41% 5.98% 2.42% 0.76% 0.92% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -1.05% -0.85% - - - 0.73% - - - -0.07% -
Cost of Revenue to Revenue		 80.46% 81.40% 77.79% 75.27% 76.56% 75.97% 76.02% 75.08% 75.15% 75.18% 75.31%
SG&A Expenses to Revenue		 14.65% 13.08% 14.33% 16.56% 15.88% 14.93% 15.16% 14.95% 15.15% 13.84% 13.88%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 21.63% 20.04% 24.13% 24.73% 24.75% 22.60% 23.36% 23.47% 24.36% 24.91% 23.37%
Earnings before Interest and Taxes (EBIT)		 -30 -27 -236 0.00 -11 12 5.00 14 5.00 -1.00 16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.00 6.00 -215 17 5.00 27 21 32 23 20 39
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.97 2.38 1.99 5.31 4.40 4.58 3.91 4.50 0.00 3.41 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 54.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.62 0.84 0.85 0.81 0.67 0.69 0.57 0.63 0.51 0.42 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 680.36 0.00 203.90 43.21 21.74 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.15% 0.00% 0.49% 2.31% 4.60% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.78 2.14 1.84 3.60 3.10 3.24 2.83 3.24 2.86 2.50 0.00
Enterprise Value to Revenue (EV/Rev)		 0.69 0.92 0.93 0.91 0.76 0.78 0.65 0.70 0.58 0.49 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 49.33 34.34 29.86 27.40 26.39 16.40 11.28 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 575.48 145.94 85.43 110.75 90.35 34.08 19.17 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 616.59 189.53 78.86 158.22 90.35 41.79 24.79 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 257.54 138.12 54.05 34.56 18.21 14.98 10.54 7.60 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 87.87 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.25 0.23 0.22 0.67 0.63 0.60 0.77 0.77 -113.75 0.78 0.01
Long-Term Debt to Equity		 0.24 0.22 0.21 0.64 0.60 0.60 0.76 0.77 -112.75 0.77 0.01
Financial Leverage		 0.34 0.31 0.30 0.61 2.22 0.60 0.10 0.56 -230.75 0.61 -0.15
Leverage Ratio		 2.35 2.37 2.38 3.19 6.60 3.27 2.41 3.25 -504.50 2.47 1.96
Compound Leverage Factor		 3.06 2.90 2.44 0.00 12.61 1.09 -1.45 1.39 302.70 14.84 1.83
Debt to Total Capital		 20.29% 18.59% 18.18% 40.00% 38.67% 37.67% 43.49% 43.58% 100.89% 43.67% 0.95%
Short-Term Debt to Total Capital		 0.85% 0.86% 0.74% 1.66% 1.69% 0.31% 0.29% 0.38% 0.89% 0.38% 0.43%
Long-Term Debt to Total Capital		 19.44% 17.73% 17.43% 38.34% 36.99% 37.36% 43.20% 43.20% 100.00% 43.28% 0.52%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 79.71% 81.41% 81.82% 60.00% 61.33% 62.33% 56.51% 56.42% -0.89% 56.33% 99.05%
Debt to EBITDA		 -2.15 -1.97 -2.21 5.51 4.32 3.49 4.68 4.03 2.84 2.18 0.00
Net Debt to EBITDA		 -2.06 -1.78 -1.88 5.41 4.24 3.44 3.61 2.93 2.09 1.71 0.00
Long-Term Debt to EBITDA		 -2.06 -1.88 -2.12 5.29 4.13 3.46 4.65 3.99 2.82 2.16 0.00
Debt to NOPAT		 -7.80 -9.39 -29.13 68.93 23.83 9.21 27.02 13.79 7.25 4.78 0.00
Net Debt to NOPAT		 -7.49 -8.49 -24.76 67.68 23.38 9.08 20.83 10.03 5.32 3.75 0.00
Long-Term Debt to NOPAT		 -7.47 -8.95 -27.94 66.07 22.79 9.13 26.85 13.67 7.18 4.74 0.00
Altman Z-Score		 2.57 2.56 2.05 3.65 3.43 3.58 3.25 3.58 3.32 3.31 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.30 1.26 1.33 1.17 1.14 1.17 1.29 1.31 1.25 1.25 1.38
Quick Ratio		 1.21 1.19 1.26 1.11 1.07 1.10 1.22 1.24 1.20 1.21 1.35
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1,054 -1,014 -1,038 -38 -31 3.00 32 -913 -916 0.00 -955
Operating Cash Flow to CapEx		 -13.33% -58.33% -63.64% -45.45% 63.64% 105.56% 22.22% 150.00% 350.00% 422.22% 380.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.99 1.74 1.45 2.04 2.01 2.04 1.95 2.21 2.23 2.34 0.00
Accounts Receivable Turnover		 5.43 4.62 4.01 5.17 4.85 4.78 4.52 5.69 5.21 5.02 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 38.41 35.14 26.00 32.45 0.00 32.32 0.00 36.47 0.00 0.00 0.00
Accounts Payable Turnover		 9.24 7.26 5.79 7.09 6.70 6.49 6.16 7.36 6.78 7.10 0.00
Days Sales Outstanding (DSO)		 67.17 79.02 90.99 70.56 75.19 76.36 80.69 64.10 70.01 72.68 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 39.51 50.27 63.08 51.51 54.49 56.28 59.23 49.57 53.85 51.42 0.00
Cash Conversion Cycle (CCC)		 27.66 28.75 27.91 19.05 20.70 20.07 21.46 14.53 16.16 21.26 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,975 1,945 1,964 958 942 948 940 920 919 944 968
Invested Capital Turnover		 3.48 3.15 2.66 4.04 4.12 4.15 4.27 9.20 9.78 5.08 0.00
Increase / (Decrease) in Invested Capital		 1,033 997 1,024 38 23 4.00 -28 920 919 0.00 968
Enterprise Value (EV)		 3,508 4,166 3,606 3,453 2,919 3,075 2,658 2,982 2,624 2,357 0.00
Market Capitalization		 3,120 3,833 3,294 3,074 2,559 2,721 2,308 2,651 2,290 2,000 0.00
Book Value per Share		 $9.72 $10.03 $14.04 $4.93 $4.97 $5.08 $5.04 $5.04 ($0.03) $5.05 $9.93
Tangible Book Value per Share		 ($0.13) ($0.06) $0.51 ($0.96) ($0.96) ($0.89) ($0.96) ($0.98) ($6.09) ($1.05) $3.73
Total Capital		 1,991 1,980 2,019 965 949 953 1,044 1,044 451 1,042 1,155
Total Debt		 404 368 367 386 367 359 454 455 455 455 11
Total Long-Term Debt		 387 351 352 370 351 356 451 451 451 451 6.00
Net Debt		 388 333 312 379 360 354 350 331 334 357 -176
Capital Expenditures (CapEx)		 15 12 11 11 11 18 18 16 12 18 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 292 256 268 123 105 112 107 97 92 112 155
Debt-free Net Working Capital (DFNWC)		 308 291 323 130 112 117 211 221 213 210 342
Net Working Capital (NWC)		 291 274 308 114 96 114 208 217 209 206 337
Net Nonoperating Expense (NNE)		 10 8.20 229 7.00 6.60 5.00 5.20 4.00 3.50 3.30 0.00
Net Nonoperating Obligations (NNO)		 388 333 312 379 360 354 350 331 923 357 -176
Total Depreciation and Amortization (D&A)		 32 33 21 17 16 15 16 18 18 21 23
Debt-free, Cash-free Net Working Capital to Revenue		 5.76% 5.63% 6.94% 3.24% 2.74% 2.85% 2.63% 2.29% 2.05% 2.34% 0.00%
Debt-free Net Working Capital to Revenue		 6.08% 6.40% 8.37% 3.42% 2.92% 2.98% 5.19% 5.22% 4.74% 4.38% 0.00%
Net Working Capital to Revenue		 5.74% 6.02% 7.98% 3.00% 2.51% 2.90% 5.11% 5.13% 4.65% 4.30% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.18) ($0.17) ($1.81) ($0.06) ($0.13) $0.01 ($0.01) $0.03 $0.00 ($0.03) $0.11
Adjusted Weighted Average Basic Shares Outstanding		 168.02M 133.41M 134.10M 117.58M 117.22M 116.87M 116.97M 116.89M 116.60M 115.34M 115M
Adjusted Diluted Earnings per Share		 ($0.18) ($0.17) ($1.81) ($0.06) ($0.13) $0.01 ($0.01) $0.03 $0.00 ($0.04) $0.11
Adjusted Weighted Average Diluted Shares Outstanding		 168.02M 133.41M 134.10M 117.58M 117.22M 119.46M 116.97M 119.46M 119.37M 115.79M 115M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 163.92M 163.33M 160.79M 117.63M 117.55M 117.09M 117.00M 116.98M 116.92M 116.60M 116.30M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.00 6.30 8.40 6.30 0.00 9.00 7.70 9.50 13 30 38
Normalized NOPAT Margin		 -0.49% 0.38% 0.81% 0.68% 0.00% 0.92% 0.79% 0.99% 1.32% 2.69% 3.35%
Pre Tax Income Margin		 -2.72% -1.98% -23.27% -0.86% -2.30% 0.41% -0.31% 0.62% -0.30% -0.54% 1.32%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -10.34% 0.00% 0.00% 0.00% 50.00% -100.00% 16.67% 0.00% 0.00% 0.00%

Frequently Asked Questions About RXO's Financials

When does RXO's fiscal year end?

According to the most recent income statement we have on file, RXO's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has RXO's net income changed over the last 4 years?

RXO's net income appears to be on an upward trend, with a most recent value of -$290 million in 2024, falling from $43 million in 2020. The previous period was $4 million in 2023. View RXO's forecast to see where analysts expect RXO to go next.

What is RXO's operating income?
RXO's total operating income in 2024 was -$56 million, based on the following breakdown:
  • Total Gross Profit: $985 million
  • Total Operating Expenses: $1.04 billion
How has RXO revenue changed over the last 4 years?

Over the last 4 years, RXO's total revenue changed from $3.36 billion in 2020 to $4.55 billion in 2024, a change of 35.5%.

How much debt does RXO have?

RXO's total liabilities were at $1.80 billion at the end of 2024, a 46.4% increase from 2023, and a 80.6% increase since 2021.

How much cash does RXO have?

In the past 3 years, RXO's cash and equivalents has ranged from $5 million in 2023 to $98 million in 2022, and is currently $35 million as of their latest financial filing in 2024.

How has RXO's book value per share changed over the last 4 years?

Over the last 4 years, RXO's book value per share changed from 0.00 in 2020 to 10.03 in 2024, a change of 1,002.6%.


Related Companies

This page (NYSE:RXO) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners
Buffett’s Next Move Could Shock Wall Street
In just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...
Golden Portfolio | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
URGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?
According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...
Paradigm Press | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...
Brownstone Research | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored